Julio Charles

1.0k total citations
14 papers, 543 citations indexed

About

Julio Charles is a scholar working on Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Julio Charles has authored 14 papers receiving a total of 543 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pathology and Forensic Medicine, 8 papers in Pulmonary and Respiratory Medicine and 8 papers in Epidemiology. Recurrent topics in Julio Charles's work include Systemic Sclerosis and Related Diseases (14 papers), Inflammatory Myopathies and Dermatomyositis (8 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (8 papers). Julio Charles is often cited by papers focused on Systemic Sclerosis and Related Diseases (14 papers), Inflammatory Myopathies and Dermatomyositis (8 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (8 papers). Julio Charles collaborates with scholars based in United States, Italy and Canada. Julio Charles's co-authors include Shervin Assassi, Maureen D. Mayes, Minghua Wu, Gloria A. Salazar, Sandeep K. Agarwal, John D. Reveille, Frank C. Arnett, Filemon K. Tan, Dinesh Khanna and Rosa M. Estrada‐Y‐Martin and has published in prestigious journals such as The FASEB Journal, Annals of the Rheumatic Diseases and Lara D. Veeken.

In The Last Decade

Julio Charles

14 papers receiving 535 citations

Peers

Countries citing papers authored by Julio Charles

Since Specialization

Citations

This map shows the geographic impact of Julio Charles's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julio Charles with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julio Charles more than expected).

Fields of papers citing papers by Julio Charles

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julio Charles. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julio Charles. The network helps show where Julio Charles may publish in the future.

Co-authorship network of co-authors of Julio Charles

This figure shows the co-authorship network connecting the top 25 collaborators of Julio Charles. A scholar is included among the top collaborators of Julio Charles based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julio Charles. Julio Charles is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work	Indexed citations
1	Unraveling the role of MiR ‐181 in skin fibrosis pathogenesis by targeting NUDT21 2024 ·The FASEB Journal ·Tingting Mills, Minghua Wu, (unknown), (unknown), Julio Charles, Zheng Chen, Seung‐Hee Yoo, Maureen D. Mayes, Shervin Assassi	6
2	Reduced digestion of circulating genomic DNA in systemic sclerosis patients with the DNASE1L3 R206C variant 2023 ·Lara D. Veeken ·Brian Skaug, Xinjian Guo, (unknown), Julio Charles, (unknown), Jacob Couturier, Dorothy E. Lewis, Claudia Bracaglia, Ivan Caiello, Maureen D. Mayes, Shervin Assassi	5
3	False positive anti-Topoisomerase I (Scl-70) antibody results in clinical practice: A case series from a scleroderma referral center 2022 ·Seminars in Arthritis and Rheumatism ·(unknown), Shervin Assassi, Julio Charles, (unknown), (unknown), (unknown), Maureen D. Mayes, Brian Skaug	3
4	The Effect of Anti‐Scl‐70 Antibody Determination Method on Its Predictive Significance for Interstitial Lung Disease Progression in Systemic Sclerosis 2022 ·ACR Open Rheumatology ·(unknown), Gloria A. Salazar, Marie Hudson, Marvin J. Fritzler, (unknown), Rosa M. Estrada‐Y‐Martin, Julio Charles, (unknown), Maureen D. Mayes, Shervin Assassi	13
5	Large-scale analysis of longitudinal skin gene expression in systemic sclerosis reveals relationships of immune cell and fibroblast activity with skin thickness and a trend towards normalisation over time 2021 ·Annals of the Rheumatic Diseases ·Brian Skaug, (unknown), William R. Swindell, Gloria A. Salazar, Minghua Wu, Tuan M. Tran, Julio Charles, (unknown), Maureen D. Mayes, Shervin Assassi	15
6	The MUC5B promoter variant does not predict progression of interstitial lung disease in systemic sclerosis 2020 ·Seminars in Arthritis and Rheumatism ·Elizabeth R. Volkmann, Donald P. Tashkin, Michael D. Roth, Ning Li, Julio Charles, Maureen D. Mayes, Grace Kim, Jonathan Goldin, (unknown), Philip J. Clements, Daniel E. Furst, Dinesh Khanna, Robert M. Elashoff, Shervin Assassi	4
7	Progression of Interstitial Lung Disease in Systemic Sclerosis: The Importance of Pneumoproteins Krebs von den Lungen 6 and CCL18 2019 ·Arthritis & Rheumatology ·Elizabeth R. Volkmann, Donald P. Tashkin, Masataka Kuwana, Ning Li, Michael D. Roth, Julio Charles, Faye N. Hant, Galina S. Bogatkevich, Tanjina Akter, Grace Kim, Jonathan Goldin, Dinesh Khanna, Philip J. Clements, Daniel E. Fürst, Robert M. Elashoff, Richard M. Silver, Shervin Assassi	61
8	KL-6 But Not CCL-18 Is a Predictor of Early Progression in Systemic Sclerosis-related Interstitial Lung Disease 2018 ·The Journal of Rheumatology ·Gloria A. Salazar, Masataka Kuwana, Minghua Wu, Rosa M. Estrada‐Y‐Martin, Binwu Ying, Julio Charles, Maureen D. Mayes, Shervin Assassi	58
9	CCL2 in the Circulation Predicts Long‐Term Progression of Interstitial Lung Disease in Patients With Early Systemic Sclerosis: Data From Two Independent Cohorts 2017 ·Arthritis & Rheumatology ·Minghua Wu, Murray Baron, Claudia Pedroza, Gloria A. Salazar, Binwu Ying, Julio Charles, Sandeep K. Agarwal, Marie Hudson, Janet Pope, Xiaodong Zhou, John D. Reveille, Marvin J. Fritzler, Maureen D. Mayes, Shervin Assassi	63
10	Changes in plasma CXCL4 levels are associated with improvements in lung function in patients receiving immunosuppressive therapy for systemic sclerosis-related interstitial lung disease 2016 ·Arthritis Research & Therapy ·Elizabeth R. Volkmann, Donald P. Tashkin, Michael D. Roth, Philip J. Clements, Dinesh Khanna, Daniel E. Furst, Maureen D. Mayes, Julio Charles, Chi‐Hong Tseng, Robert M. Elashoff, Shervin Assassi	59
11	Autoantibodies to Dense Fine Speckles in Pediatric Diseases and Controls 2015 ·The Journal of Rheumatology ·Heinrike Schmeling, Michael Mähler, Deborah M. Levy, (unknown), Anne M. Stevens, James Wick, (unknown), Gerd Horneff, Shervin Assassi, Julio Charles, Gloria A. Salazar, Maureen D. Mayes, Earl D. Silverman, (unknown), (unknown), Hermine I. Brunner, Ann M. Reed, Marvin J. Fritzler	27
12	Can Serum Surfactant Protein D or CC-Chemokine Ligand 18 Predict Outcome of Interstitial Lung Disease in Patients with Early Systemic Sclerosis? 2013 ·The Journal of Rheumatology ·(unknown), Julio Charles, Claudia Pedroza, Xiaochun Liu, Xiaodong Zhou, Rosa M. Estrada‐Y‐Martin, Emilio B. González, Dorothy E. Lewis, Hilda T. Draeger, (unknown), Frank C. Arnett, Maureen D. Mayes, Shervin Assassi	47
13	Skin Gene Expression Correlates of Severity of Interstitial Lung Disease in Systemic Sclerosis 2013 ·Arthritis & Rheumatism ·Shervin Assassi, Minghua Wu, Filemon K. Tan, Jeffrey T. Chang, (unknown), Daniel E. Furst, Dinesh Khanna, Julio Charles, Emma Ferguson, Carol Feghali‐Bostwick, Maureen D. Mayes	37
14	Systemic sclerosis and lupus: Points in an interferon‐mediated continuum 2010 ·Arthritis & Rheumatism ·Shervin Assassi, Maureen D. Mayes, Frank C. Arnett, Pravitt Gourh, Sandeep K. Agarwal, Terry A. McNearney, Damien Chaussabel, (unknown), Michael A. Fischbach, (unknown), Julio Charles, Virginia Pascual, John D. Reveille, Filemon K. Tan	145

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact